Skip to content
Search

Latest Stories

Half a million more at risk of type 2 diabetes in England in one year

Half a million more at risk of type 2 diabetes in England in one year

There was an almost 25 per cent increase in the number of individuals under the age of 40 at risk of type 2 diabetes

The number of people in England identified as at risk for type 2 diabetes mellitus (T2DM) has increased by over half a million within a year, according to NHS figures.


Data released by the National Diabetes Audit on June 12 showed that 3.6 million people registered with a GP were found to have non-diabetic hyperglycaemia (also known as pre-diabetes) in 2023, compared with 3.1 million people in 2022 — a notable 18 per cent increase or nearly 550,000 people.

Among those under 40 years old, the figures showed an increase of almost 25 per cent from 173,166 in 2022 to 216,440 in 2023.

People with non-diabetic hyperglycaemia have higher-than-normal blood sugar levels, and they are at greater risk for developing type 2 diabetes and cardiovascular diseases. Typically, this condition is detected through routine blood tests at GP surgeries.

Amanda Pritchard, NHS chief executive, expressed deep concern over the figures, emphasising that type 2 diabetes is not only linked to kidney failure, amputation, heart attack, stroke, and many of the common types of cancer, but it also adds pressure to NHS services.

She assured that the NHS will continue to develop services that support people at risk of developing type 2 diabetes to lead healthier lives.

The NHS has introduced a range of innovative services to prevent people from developing type 2 diabetes and to reduce obesity rates, including the world-leading Healthier You NHS Diabetes Prevention Programme.

More than 1.6 million people have been offered support through the nine-month programme, which provides personalised support with practical tools and advice on healthy eating and lifestyle, increasing physical activity and weight management.

Dr. Clare Hambling, National Clinical Director of Diabetes and Obesity at NHS England, highlighted that the prevalence of type 2 diabetes among individuals under 40 is increasing worldwide, including in England.

According to the NHS, around nine out of 10 people in England living with diabetes have type 2.

The NHS England-funded Type 2 Diabetes and the Young (T2DAY) initiative ensures that people living with early-onset type 2 diabetes receive all recommended diabetes health checks, personalised support tailored to their needs, and evidence-based management to stay well and avoid complications.

It includes additional clinical reviews for those aged 18 to 39 years old living with type 2 diabetes.

The ambitious programme, now entering its second year, is believed to be the world-first targeted support for these high-risk people living with diabetes.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less